2026 PDA Board of Directors Election

As Director Scientific Affairs, Integrated Systems, at West Pharmaceutical Services, Dr. Bettine Boltres supports scientific exchange between West and the pharmaceutical industry. This is complementing her past work as Product Manager for Schott Pharmaceutical Tubing, where she provided scientific consulting for glass primary packaging.

Bettine is an active member of the USP Packaging and Distribution Expert Committee, the European Pharmacopoeia Commission Group of Experts 16 (elastomers and plastics) and the GLS Working Party (glass). She is a member of ISO Working Group 4 (Elastomers) and Working Group 2 (glass). Additionally, Bettine is on the PDA Board of Directors and in 2015 she published the book “When Glass Meets Pharma”, which builds the bridge between glass for pharmaceutical primary packaging and drug substances.

Dr. Boltres is a (bio)chemist by training, receiving a diploma in chemistry from the university of Frankfurt, Germany and a PhD in biochemistry from the university of Cologne, Germany.

Dr. Emma Ramnarine is an accomplished senior leader with 22+ years of global experience in the pharmaceutical, biotechnology and medical device industries in Analytical Science & Technology, Product Lifecycle Management, Outsourcing & External Collaborations, Risk Management, QC and Quality Management Systems. She was most recently Executive Director, Global Head of External Development Collaborations at Genentech/Roche, managing the external network for development, manufacturing, and clinical collaborations of Roche’s Biologics and Small Molecules development portfolio.

She is a well-recognized industry thought leader and expert on QRM and risk-based applications, providing expertise and training for regulatory authorities and the industry. She is currently Co-lead for the Industry One-Voice-of-Quality (1VQ) Initiative on Post Approval Changes, an initiative sponsored by Chief Quality Officers of more than 25 global pharma companies.

Emma is currently Secretary of the PDA Board and is in the Board since 8 y. She was also on RAQAB, and has led several PDA Task Forces, Interest Group and Technical Reports (TR).

Emma holds a PhD in Pharmaceutical Sciences from TU Dublin, Ireland, an MS in Pharmaceutical Sciences from the University of Connecticut, an M Pharm and a B Pharm, both from the School of Pharmacy, SGSITS, Indore, India.

He has been an active PDA member for over 25 years and is presently serving on the Board of Directors and the PDA/FDA Joint Regulatory Conference planning committee for the past few years.   Additionally, Marc has co-chaired several Technical Reports and Points to Consider publications and served on the Education, Science and ATMP Advisory Boards.

In 2020, Marc was the recipient of the James P. Agalloco award for his efforts at PDA’s Training and Research Institute, the 2022 Michael Korczynski Award for his support of PDA’s international activities and a Service Appreciation Award in 2023 for his time spent as the Microbiology/EM Interest Group co-lead. 

Marc earned his B.S. in Biology from Monmouth University and his M.S. in Microbiology & Molecular Genetics from Rutgers University.

Austin Caudle is the Vice President of Business Development at SmartSkin Technologies. In this role, he leads strategic partnerships and customer engagement. His guidance aims to accelerate the adoption of SmartSkin’s technologies and achieve higher levels of regulatory confidence. Before joining SmartSkin, he was at Redica Systems, a SaaS software company specializing in Quality and regulatory compliance data intelligence, where he helped establish the company as a leader in this space.

Austin is the Immediate Past-President of the Southeast Chapter and a current member of the RAQAB. He also serves as a Regulatory Authority Engagement Liaison for the EMA Quality Working Party. In 2025, the Southeast Chapter was recognized as Chapter of the Year under his leadership. He has contributed to the PDA Letter and participated in numerous conferences as a moderator and planning committee member.

Austin holds a BSc and MSc in Nutrition & Food Science from Auburn University and has published research in several scientific journals.

Cristiana Campa currently works at GSK as External CMC Intelligence Lead, with more than 20 years’ experience in Chemistry, Manufacturing and Control (CMC) for biologics research and development. She is actively promoting dialogue across industry and with Regulatory Agencies on several topics, including innovative technologies, specifications setting, stability, accelerated development, and pandemic preparedness. For instance, she has been co-chair, committee member and speaker in several PDA events, co-author of the PDA Technical Report 89, and co- editor of a PDA cross-company book on Quality by Design (QbD). In 2023, she has joined the PDA Board of Directors (cycle 2023-2025), and, since 2024, she is the EFPIA lead in the ICH Expert Working Group for ICH Q6 (specifications) Guideline revision, co-chair of the PDA Vaccine Interest Group, and chair of the Vaccines Europe/ IFPMA CMC Adaptive Pathways team. Since 2025, she is a member of the Vaccines Expert Committee of the US Pharmacopoeia. After her PhD and Post-Doc in Chemistry, she has held several leadership roles including Head of Research Laboratory at Bracco Imaging, Head of Analytical Development at Novartis Vaccines, Head of QbD Integration, and Head of Science and Development Practices, and Global Advisor in Technical R&D at GSK Vaccines.

Cylia brings over 25 years of experience in the biopharmaceutical industry. She currently serves as Sr. Director at Amgen, where she and her team provide oversight of the Contract Manufacturing Operations. Since joining Amgen in 2006, she has held various roles across Quality, Manufacturing, Strategic Planning, and Process Development.

Earlier in her career, Cylia supported process validation and startup of new fill-finish facilities while consulting with Baxter and Watson. She holds a Master of Science in Regulatory Sciences and a Bachelor of Science in Biomedical Engineering, both from the University of Southern California.

Within PDA, Cylia has demonstrated a long-standing commitment to advancing industry practices. She led the PDA task force on Quality Metrics and Culture, spearheading the development of the PDA Quality Culture Assessment Tool—resources that US FDA inspectors and MHRA have been trained on. She also contributed to the ANSI Quality Culture standards initiative and served for six years on PDA’s Regulatory Affairs and Quality Advisory Board (RAQAB).

Jackie Veivia-Panter is a distinguished leader in the pharmaceutical and cell and gene therapy industries, with over 30 years of expertise in quality assurance. As a dedicated member of the Parenteral Drug Association (PDA) for more than 20 years, Jackie has significantly shaped the organization’s initiatives. Her contributions include serving on regulatory commenting teams, the PDA-FDA Joint Regulatory Conference planning committee, and as chair of both the Data Integrity and CDMO workshops. She has also held leadership roles as Vice Chair, Chair, and Past Chair of the Regulatory and Quality Advisory Board (RAQAB) and was a member of the Advanced Therapy Medicinal Products Advisory Board (ATMP AB).

In the past year, Jackie faced a personal challenge with metastatic breast cancer, which temporarily limited her active participation in PDA. This experience has enriched her perspective, providing a profound understanding of the patient journey which she now integrates into her professional work. Jackie’s LinkedIn profile (Jackie Veivia-Panter) reflects her extensive experience and unwavering commitment to advancing pharmaceutical science and regulatory excellence through collaboration and innovation.

Jeff Broadfoot has over 30 years years of experience in pharmaceutical manufacturing including vaccines, plasma-derived protein therapeutics, monoclonals, tablets and capsules, and medical devices. This includes oversight of Quality teams supporting drug substance and drug product manufacturing, including aseptic filling operations, across North America and Europe. Currently Jeff is the VP Quality Operations and is responsible for Quality oversight of all internal and external manufacturing operations at Emergent.

Jeff obtained a Diploma in Bioengineering and Chemical Technology from Red River College, and an MBA from Simon Fraser University.

Jeff served for 13 years on the Regulatory Affairs and Quality Advisory Board, including 3 years as Chair. He contributed to the development of PDA Standard 06-2025 on Quality Culture as well as PDA Technical Report 84 (Integrating Data Integrity Requirements into Manufacturing), served as Co-Chair of PDA’s Quality Management Maturity Task Force, and has co-authored or authored articles appearing in the PDA Letter on Quality Culture, PDA’s Quality Culture Survey, and Quality Maturity. Jeff has also been a panelist at PDA signature conferences discussing data integrity as well as the role of Quality in pharmaceutical manufacturing.

Vishal has more than 25 years of experience in the domains of Sterile Manufacturing and Microbiology.

He is associated in many formats with being a PDA member from 2010, is a founding member for the India Chapter, and is a past president. During his role as India Chapter President, he was instrumental in forging close relations with other chapters, notably Singapore and Australia. Vishal is involved deeply in expanding PDA-TRI footprint, with his commitment to teach the science of regulations, operations and microbiology in India and beyond. He was involved with the task force for, “PDA Points to Consider in Remote and Hybrid GMP/GDP Audits and Inspections”, and is currently part of the task force revising, “PDA Tech Report # 3, Validation of Dry Heat Processes Used for Depyrogenation and Sterilization”. He is a member of PDA, Regulatory Affairs and Quality Advisory Board (RAQAB).

Vishal has also presented a poster at Kilmer Conference - 2022, Greece on, “Novel Approach to Aseptic Processing/Microbiology Training”

Vishal has completed his B.Sc. in Biology and M.Sc. in Microbiology from M.D.S. University, Ajmer, India.